Press Releases for AUXL

Press Releases
Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference
Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
Auxilium Pharmaceuticals to Announce Third Quarter 2009 Results and Conduct Conference Call on Wednesday, October 28, 2009
Jefferies Expands International Healthcare Investment Banking Platform
Auxilium Pharmaceuticals Completes Sale of 3.45 Million Shares of Common Stock Resulting in $115.7 Million in Net Proceeds
Auxilium Pharmaceuticals, Inc. Announces Pricing of a Public Offering of Common Stock
Auxilium Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners 2009 Healthcare Conference
BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights
Auxilium Pharmaceuticals, Inc. Secures $30 Million Revolving Credit Line With Silicon Valley Bank
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Auxilium Pharmaceuticals to Announce Second Quarter 2009 Results and Conduct Conference Call on Thursday, August 6, 2009
Data Presented at the 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected in HIV-Positive Men
Auxilium Pharmaceuticals Selects Cegedim Dendrite SaaS CRM Solution
Shawn Cross Joins Burrill Merchant Banking
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare Conference
Repros Therapeutics Inc. Reports First Quarter 2009 Financial Results and Provides Clinical Program Update
BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
Testosterone gel causes safety concerns
CPEX Pharmaceuticals Reports First-Quarter 2009 Financial Results
Auxilium Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results and Operational Highlights
Auxilium Pharmaceuticals to Present at the Deutsche Bank 34th Annual Health Care Conference
Auxilium Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
Auxilium Pharmaceuticals to Announce First Quarter 2009 Results and Conduct Conference Call on Wednesday, May 6, 2009
Zacks Analyst Blog Highlights: PepsiCo, Dr. Pepper Snapple Group, Auxilium Pharmaceuticals, Myriad Genetics and Autoliv, Inc. - Mar 27 2009 11:55PM
Zacks Analyst Blog Highlights: PepsiCo, Dr. Pepper Snapple Group, Auxilium Pharmaceuticals, Myriad Genetics and Autoliv, Inc. - Mar 27 2009 7:00AM
William T. McKee Joins Board of Auxilium Pharmaceuticals, Inc.
Auxilium Pharmaceuticals to Present at Citi's 4th Annual Biotech Day
Auxilium Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
Auxilium Submits Biologics License Application for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture to the U.S. Food and Drug Administration
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results, as Well as Guidance for 2009
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2008 Results and Conduct Conference Call on Wednesday, February 18, 2009
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Phase IIb Clinical Trial of XIAFLEX(TM) in Peyronie's Disease
BenchmarkJournal.Com (Complimentary) Analyst Review for and EXPE, GOLD, AUXL and ASTM
Auxilium Pharmaceuticals, Inc. and Pfizer Enter Agreement to Develop and Commercialize XIAFLEX(TM) in Europe
Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim(R) Patent
Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim(R) in Europe With Ferring Pharmaceuticals
Auxilium Pharmaceuticals to Present at the Piper Jaffray 20th Annual Healthcare Conference
Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results and Operational Highlights
Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. Receive Paragraph IV Certification Notice From Upsher-Smith Laboratories for Testim(R)
Auxilium Pharmaceuticals to Present at the 19th Annual Oppenheimer Healthcare Conference
Auxilium Pharmaceuticals to Announce Third Quarter 2008 Results and Conduct Conference Call on Wednesday, October 29, 2008
Auxilium Pharmaceuticals to Present at the 2008 UBS Global Life Sciences Conference
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(TM) Phase IIb Study for Peyronie's Disease
Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference - Sep 2 2008 7:13AM
Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
Agile Therapeutics Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results and Operational Highlights
Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July 31, 2008
Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
/ CORRECTION - Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
BellwetherReport.com Analyst Report on AUXL, ROYL, LULU and GRMN
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Auxilium Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference - May 27 2008 12:59AM
Auxilium Pharmaceuticals to Present at the Citigroup 2008 Global Healthcare Conference - Jun 1 2008 10:30AM
Auxilium Pharmaceuticals to Present At the Bank of America 2008 Healthcare Conference - Jun 1 2008 10:30AM
Auxilium Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results and Operational Highlights
Auxilium Pharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference - Jun 1 2008 10:30AM
Auxilium Pharmaceuticals to Announce First Quarter 2008 Results and Conduct Conference Call on Wednesday, April 30, 2008